Integrating MRI Volume and Plasma p-Tau217 for Amyloid Risk Stratification in Early-Stage Alzheimer Disease.

Yim S, Park S, Lim K, Kang H, Shin D, Jo H, Jang H, Weiner MW, Zetterberg H, Blennow K, Gonzalez-Ortiz F, Ashton NJ, Kang SH, Yun J, Chun MY, Kim EJ, Kim HJ, Na DL, Kim JP, Seo SW, Kwak K; K-ROAD study and the Alzheimer's Disease Neuroimaging Initiative.